ATE531390T1 - Interleukin-15-(il-15-)spezifische menschliche antikörper - Google Patents

Interleukin-15-(il-15-)spezifische menschliche antikörper

Info

Publication number
ATE531390T1
ATE531390T1 AT02796411T AT02796411T ATE531390T1 AT E531390 T1 ATE531390 T1 AT E531390T1 AT 02796411 T AT02796411 T AT 02796411T AT 02796411 T AT02796411 T AT 02796411T AT E531390 T1 ATE531390 T1 AT E531390T1
Authority
AT
Austria
Prior art keywords
human
antibodies
human antibodies
interleukin
specific human
Prior art date
Application number
AT02796411T
Other languages
German (de)
English (en)
Inventor
De Winkel Jan Van
Dijk Marcus Van
Janine Schuurman
Arnout Gerritsen
Ole Baadsgaard
Original Assignee
Genmab As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genmab As filed Critical Genmab As
Application granted granted Critical
Publication of ATE531390T1 publication Critical patent/ATE531390T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02796411T 2001-08-23 2002-08-23 Interleukin-15-(il-15-)spezifische menschliche antikörper ATE531390T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31473101P 2001-08-23 2001-08-23
PCT/US2002/026769 WO2003017935A2 (en) 2001-08-23 2002-08-23 Human antibodies specific for interleukin 15 (il-15)

Publications (1)

Publication Number Publication Date
ATE531390T1 true ATE531390T1 (de) 2011-11-15

Family

ID=23221192

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02796411T ATE531390T1 (de) 2001-08-23 2002-08-23 Interleukin-15-(il-15-)spezifische menschliche antikörper

Country Status (24)

Country Link
US (1) US7153507B2 (pl)
EP (1) EP1425389B1 (pl)
JP (2) JP4359503B2 (pl)
KR (1) KR100911951B1 (pl)
CN (1) CN100557018C (pl)
AT (1) ATE531390T1 (pl)
AU (1) AU2002332628B2 (pl)
BR (1) BR0212136A (pl)
CA (1) CA2456648C (pl)
CY (1) CY1112447T1 (pl)
DK (1) DK1425389T3 (pl)
EA (1) EA014802B1 (pl)
ES (1) ES2375271T3 (pl)
HU (1) HU229776B1 (pl)
IL (2) IL160358A0 (pl)
MX (1) MXPA04001486A (pl)
NO (1) NO333152B1 (pl)
NZ (1) NZ531211A (pl)
PL (1) PL217752B1 (pl)
PT (1) PT1425389E (pl)
RS (1) RS51829B (pl)
SI (1) SI1425389T1 (pl)
WO (1) WO2003017935A2 (pl)
ZA (1) ZA200401144B (pl)

Families Citing this family (300)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2817619A1 (en) 2001-06-08 2002-12-08 Abbott Laboratories (Bermuda) Ltd. Methods of administering anti-tnf.alpha. antibodies
US7247304B2 (en) 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
KR100911951B1 (ko) 2001-08-23 2009-08-13 젠맵 에이/에스 인터루킨 15 (ｉｌ-15)에 대하여 특이적인 인간 항체
US7329405B2 (en) 2001-08-23 2008-02-12 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
GB0208817D0 (en) * 2002-04-17 2002-05-29 European Molecular Biology Lab Embl Method for producing monoclonal antibodies
EA015897B1 (ru) * 2003-02-26 2011-12-30 Генмаб А/С Применение человеческого моноклонального антитела к ил-15 в составе композиции и лекарственного препарата (варианты), композиция и лекарственный препарат, его включающие
NZ570709A (en) 2003-06-13 2010-04-30 Univ Pennsylvania Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
US20050123542A1 (en) * 2003-11-06 2005-06-09 Genmab A/S Methods for treating disorders involving monocytes
EP1805320B1 (en) * 2004-10-22 2014-09-03 Amgen Inc. Methods for refolding of recombinant antibodies
ZA200704908B (en) * 2004-12-13 2008-10-29 Cytos Biotechnology Ag IL-15 Antigen Arrays and uses thereof
JP5757495B2 (ja) * 2005-05-16 2015-07-29 アッヴィ バイオテクノロジー リミテッド びらん性多発性関節炎の治療のためのｔｎｆ阻害剤の使用
JP2008543839A (ja) * 2005-06-14 2008-12-04 アムジェン インコーポレーテッド 自己緩衝タンパク質製剤
US20070190057A1 (en) 2006-01-23 2007-08-16 Jian Wu Methods for modulating mannose content of recombinant proteins
US9399061B2 (en) * 2006-04-10 2016-07-26 Abbvie Biotechnology Ltd Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis
US9605064B2 (en) 2006-04-10 2017-03-28 Abbvie Biotechnology Ltd Methods and compositions for treatment of skin disorders
US20080131374A1 (en) * 2006-04-19 2008-06-05 Medich John R Uses and compositions for treatment of rheumatoid arthritis
US7834154B2 (en) 2007-02-09 2010-11-16 Genentech, Inc. Anti-ROBO4 antibodies and uses therefor
EP2171451A4 (en) 2007-06-11 2011-12-07 Abbott Biotech Ltd METHOD FOR TREATING JUVENILIAN IDIOPATHIC ARTHRITIS
AU2008293425B2 (en) * 2007-08-31 2014-09-18 Amgen Inc. Solid-state protein formulation
JP5963341B2 (ja) * 2007-09-14 2016-08-10 アムジエン・インコーポレーテツド 均質な抗体集団
AU2008304111B2 (en) 2007-09-27 2014-04-24 Amgen Inc. Pharmaceutical formulations
US8796206B2 (en) 2007-11-15 2014-08-05 Amgen Inc. Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration
TWI468417B (zh) 2007-11-30 2015-01-11 Genentech Inc 抗－ｖｅｇｆ抗體
EP2098536A1 (en) 2008-03-05 2009-09-09 4-Antibody AG Isolation and identification of antigen- or ligand-specific binding proteins
MX2010010503A (es) * 2008-03-24 2010-11-09 Abbott Biotech Ltd Metodos y composiciones para tratar perdida osea.
CU23716A1 (es) 2008-09-30 2011-10-05 Ct Ingenieria Genetica Biotech Péptido antagonista de la actividad de la interleucina-15
UA109633C2 (uk) 2008-12-09 2015-09-25 Антитіло людини проти тканинного фактора
TW201106972A (en) 2009-07-27 2011-03-01 Genentech Inc Combination treatments
JP5887270B2 (ja) 2009-09-02 2016-03-16 ジェネンテック， インコーポレイテッド 突然変異体ｓｍｏｏｔｈｅｎｅｄおよびその使用方法
US9662271B2 (en) 2009-10-23 2017-05-30 Amgen Inc. Vial adapter and system
US8486397B2 (en) 2009-12-11 2013-07-16 Genentech, Inc. Anti-VEGF-C antibodies and methods using same
CN107095846A (zh) 2009-12-21 2017-08-29 霍夫曼-拉罗奇有限公司 抗体配制剂
ES2545411T5 (es) 2010-06-07 2024-04-05 Amgen Inc Dispositivo de administración de fármaco
EP2580243B1 (en) 2010-06-09 2019-10-16 Genmab A/S Antibodies against human cd38
JP6055404B2 (ja) 2010-06-15 2016-12-27 ゲンマブ エー／エス 組織因子に対するヒト抗体薬物結合体
US8481680B2 (en) 2010-10-05 2013-07-09 Genentech, Inc. Mutant smoothened and methods of using the same
WO2012135315A1 (en) 2011-03-31 2012-10-04 Amgen Inc. Vial adapter and system
LT2699293T (lt) 2011-04-20 2019-04-25 Amgen Inc. Automatinio purškimo prietaisas
CN102250243B (zh) * 2011-07-01 2013-08-28 华绍炳 抗白细胞介素-15抗体
ES2682750T5 (en) * 2011-07-18 2025-02-04 Iba Lifesciences Gmbh Method of reversibly staining a target cell
EP3045187B1 (en) 2011-10-14 2019-04-10 Amgen Inc. Injector and method of assembly
JP2015535464A (ja) 2012-11-21 2015-12-14 アムジエン・インコーポレーテツド 薬剤送達装置
DK3896088T3 (da) 2013-02-20 2025-09-29 Innate Pharma Behandling af perifert t-cellelymfom
MX365567B (es) 2013-03-13 2019-06-07 Genentech Inc Formulaciones de anticuerpo.
US20140314778A1 (en) 2013-03-13 2014-10-23 Genentech, Inc. Formulations with reduced oxidation
US10653779B2 (en) 2013-03-13 2020-05-19 Genentech, Inc. Formulations with reduced oxidation
SG11201507043SA (en) 2013-03-13 2015-10-29 Genentech Inc Formulations with reduced oxidation
HK1212613A1 (zh) 2013-03-13 2016-06-17 豪夫迈‧罗氏有限公司 具有降低的氧化的配制物
SG10201809452RA (en) 2013-03-15 2018-11-29 Genentech Inc Cell culture compositions with antioxidants and methods for polypeptide production
US10492990B2 (en) 2013-03-15 2019-12-03 Amgen Inc. Drug cassette, autoinjector, and autoinjector system
US10092703B2 (en) 2013-03-15 2018-10-09 Amgen Inc. Drug cassette, autoinjector, and autoinjector system
TWI592183B (zh) 2013-03-15 2017-07-21 安美基公司 本體輪廓可調適之自動注射器裝置
ES2853748T3 (es) 2013-03-22 2021-09-17 Amgen Inc Inyector y método de montaje
DK3049441T3 (da) 2013-09-27 2020-02-03 Hoffmann La Roche Anti-PDL1-antistofformuleringer
MX2016005315A (es) 2013-10-24 2016-08-11 Amgen Inc Sistema de administracion de farmacos con control sensible a la temperatura.
EP3060275B1 (en) 2013-10-24 2019-07-03 Amgen Inc. Injector and method of assembly
ES2763429T5 (es) 2013-12-17 2023-06-21 Hoffmann La Roche Procedimientos de tratamiento de cánceres usando antagonistas de la unión al eje de PD-1 y taxanos
MX2016007965A (es) 2013-12-17 2016-10-28 Genentech Inc Terapia de combinacion que comprende agonistas de union a ox40 y antagonistas de union al eje pd-1.
US20150210772A1 (en) 2013-12-17 2015-07-30 Genentech, Inc. Methods of treating cancer using pd-1 axis binding antagonists and an anti-cd20 antibody
US20170044232A1 (en) 2014-02-04 2017-02-16 Genentech, Inc. Mutant smoothened and methods of using the same
WO2015119906A1 (en) 2014-02-05 2015-08-13 Amgen Inc. Drug delivery system with electromagnetic field generator
KR20160146747A (ko) 2014-03-31 2016-12-21 제넨테크, 인크. 항혈관신생제 및 ox40 결합 효능제를 포함하는 조합 요법
SG11201609219QA (en) 2014-05-07 2016-12-29 Amgen Inc Autoinjector with shock reducing elements
US20170103186A1 (en) 2014-06-03 2017-04-13 Amgen Inc. Systems and methods for supporting patient use of a drug delivery device
EP2963057A1 (en) 2014-07-02 2016-01-06 Calypso Biotech SA Antibodies to IL-15
ES2949173T3 (es) 2014-09-15 2023-09-26 Hoffmann La Roche Formulaciones de anticuerpo
ES3056224T3 (en) 2014-10-14 2026-02-19 Amgen Inc Drug injection device with visual and audible indicators
ES2964713T3 (es) 2014-10-23 2024-04-09 Amgen Inc Reducción de la viscosidad de formulaciones farmacéuticas
CN106999583A (zh) 2014-11-17 2017-08-01 豪夫迈·罗氏有限公司 包含ox40结合激动剂和pd‑1轴结合拮抗剂的组合疗法
US10799630B2 (en) 2014-12-19 2020-10-13 Amgen Inc. Drug delivery device with proximity sensor
EP3689394A1 (en) 2014-12-19 2020-08-05 Amgen Inc. Drug delivery device with live button or user interface field
CN107636170A (zh) 2015-02-04 2018-01-26 健泰科生物技术公司 突变型Smoothened及其使用方法
US10583245B2 (en) 2015-02-17 2020-03-10 Amgen Inc. Drug delivery device with vacuum assisted securement and/or feedback
ES2905870T3 (es) 2015-02-27 2022-04-12 Amgen Inc Dispositivo de suministro de fármacos que tiene un mecanismo de protección de aguja con un umbral de resistencia ajustable al movimiento de la protección de aguja
HRP20260689T1 (hr) 2015-06-17 2026-07-17 F. Hoffmann-La Roche Ag Postupci za liječenje lokalno uznapredovalog ili metastatskog raka dojke primjenom antagonista vezivanja osi pd-1 i taksana
JOP20160131B1 (ar) 2015-06-26 2022-03-14 Novartis Ag الأجسام المضادة للعامل xi وطرق الاستخدام
TW202440903A (zh) 2015-08-04 2024-10-16 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法（一）
ES2964640T3 (es) 2015-08-13 2024-04-08 Amgen Inc Filtración en profundidad cargada de proteínas de unión al antígeno
WO2017039786A1 (en) 2015-09-02 2017-03-09 Amgen Inc. Syringe assembly adapter for a syringe
JP7082568B2 (ja) 2015-12-09 2022-06-08 アムジエン・インコーポレーテツド 信号伝達キャップ付き自動注射器
SG10202103844WA (en) 2015-12-30 2021-06-29 Genentech Inc Use of tryptophan derivatives for protein formulations
US10525137B2 (en) 2015-12-30 2020-01-07 Genentech, Inc. Formulations with reduced degradation of polysorbate
WO2017120178A1 (en) 2016-01-06 2017-07-13 Amgen Inc. Auto-injector with signaling electronics
BR112018011029A2 (pt) 2016-01-08 2018-11-21 Hoffmann La Roche métodos para tratar ou atrasar a progressão do câncer e para melhorar a função imune em um indivíduo com câncer, usos de um antagonista de ligação e de um anticorpo biespecífico, composições e kits
AU2017213826A1 (en) 2016-02-04 2018-08-23 Curis, Inc. Mutant smoothened and methods of using the same
CN109153719B (zh) 2016-03-15 2022-12-30 中外制药株式会社 使用pd-1轴结合拮抗剂和抗gpc3抗体治疗癌症的方法
WO2017160799A1 (en) 2016-03-15 2017-09-21 Amgen Inc. Reducing probability of glass breakage in drug delivery devices
WO2017189089A1 (en) 2016-04-29 2017-11-02 Amgen Inc. Drug delivery device with messaging label
US11389588B2 (en) 2016-05-02 2022-07-19 Amgen Inc. Syringe adapter and guide for filling an on-body injector
MX2018013616A (es) 2016-05-13 2019-02-21 Amgen Inc Montaje de cubierta protectora de vial.
WO2017200989A1 (en) 2016-05-16 2017-11-23 Amgen Inc. Data encryption in medical devices with limited computational capability
TW201802121A (zh) 2016-05-25 2018-01-16 諾華公司 抗因子XI/XIa抗體之逆轉結合劑及其用途
ES3066292T3 (en) 2016-06-03 2026-05-12 Amgen Inc Impact testing apparatuses and methods for drug delivery devices
US20180002417A1 (en) * 2016-06-15 2018-01-04 Celimmune Llc Methods and Compositions for the Treatment of Celiac Disease, Non-Celiac Gluten Sensitivity, and Refractory Celiac Disease
EP3478342B1 (en) 2016-07-01 2025-03-12 Amgen Inc. Drug delivery device having minimized risk of component fracture upon impact events
WO2018029124A1 (en) 2016-08-08 2018-02-15 F. Hoffmann-La Roche Ag Therapeutic and diagnostic methods for cancer
US20190328965A1 (en) 2016-08-17 2019-10-31 Amgen Inc. Drug delivery device with placement detection
JP7275027B2 (ja) 2016-10-06 2023-05-17 アムジェン インコーポレイテッド 粘度低下タンパク質医薬製剤
ES3064802T3 (en) 2016-10-21 2026-04-29 Amgen Inc Pharmaceutical formulations and methods of making the same
EP3532127B1 (en) 2016-10-25 2026-04-08 Amgen Inc. On-body injector
HRP20250482T1 (hr) 2016-12-21 2025-06-20 Cephalon Llc Protutijela koja se specifično vežu na ljudski il-15 i njihove uporabe
KR102616666B1 (ko) 2016-12-23 2023-12-27 노파르티스 아게 인자 xi 항체 및 사용 방법
WO2018136398A1 (en) 2017-01-17 2018-07-26 Amgen Inc. Injection devices and related methods of use and assembly
MX2019009755A (es) 2017-02-17 2019-10-07 Amgen Inc Mecanismo de insercion para dispositivo de suministro de farmacos.
AU2018220538B2 (en) 2017-02-17 2023-12-14 Amgen Inc. Drug delivery device with sterile fluid flowpath and related method of assembly
JP7377596B2 (ja) 2017-02-22 2023-11-10 アムジエン・インコーポレーテツド 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
WO2018165143A1 (en) 2017-03-06 2018-09-13 Amgen Inc. Drug delivery device with activation prevention feature
KR102627069B1 (ko) 2017-03-07 2024-01-18 암겐 인코포레이티드 과압에 의한 바늘 삽입
SG11201908062QA (en) 2017-03-09 2019-09-27 Amgen Inc Insertion mechanism for drug delivery device
MX2019011416A (es) 2017-03-28 2019-11-01 Amgen Inc Sistema y metodo para conjunto de jeringa y vastago de embolo.
AU2018257917B2 (en) 2017-04-24 2023-05-04 University Of Massachusetts Diagnosis and treatment of vitiligo
US12103979B2 (en) 2017-04-28 2024-10-01 Amgen Inc. N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
CA3066399A1 (en) 2017-06-08 2018-12-13 Amgen Inc. Torque driven drug delivery device
AU2018280054B2 (en) 2017-06-08 2023-07-13 Amgen Inc. Syringe assembly for a drug delivery device and method of assembly
MA49447A (fr) 2017-06-22 2020-04-29 Amgen Inc Réduction des impacts/chocs d'activation d'un dispositif
JP7475860B2 (ja) 2017-06-23 2024-04-30 アムジエン・インコーポレーテツド スイッチアセンブリにより起動されるキャップを含む電子薬物送達デバイス
JP7408398B2 (ja) 2017-07-14 2024-01-05 アムジエン・インコーポレーテツド 二重ねじりばねシステムを有する針挿入後退システム
JP7649105B2 (ja) 2017-07-21 2025-03-19 アムジエン・インコーポレーテツド 薬物容器のためのガス透過性シーリング部材及び組立方法
WO2019022951A1 (en) 2017-07-25 2019-01-31 Amgen Inc. DRUG DELIVERY DEVICE WITH GEAR MODULE AND ASSEMBLY METHOD THEREOF
EP3658206A1 (en) 2017-07-25 2020-06-03 Amgen Inc. Drug delivery device with container access system and related method of assembly
EA202090399A1 (ru) 2017-08-01 2020-05-20 Эмджен Инк. Системы и способы для подготовки в режиме реального времени образца полипептида для анализа с помощью масс-спектрометрии
BR112020001922A2 (pt) 2017-08-01 2020-08-04 Amgen Inc. sistemas e métodos para realização de um ensaio de glicanas em tempo real de uma amostra
US12318593B2 (en) 2017-08-09 2025-06-03 Amgen Inc. Hydraulic-pneumatic pressurized chamber drug delivery system
EP3668567B1 (en) 2017-08-18 2026-02-18 Amgen Inc. Wearable injector with sterile adhesive patch
US11103636B2 (en) 2017-08-22 2021-08-31 Amgen Inc. Needle insertion mechanism for drug delivery device
EP3691717B1 (en) 2017-10-04 2023-02-08 Amgen Inc. Flow adapter for drug delivery device
EP4257164A3 (en) 2017-10-06 2024-01-17 Amgen Inc. Drug delivery device with interlock assembly and related method of assembly
MA50348A (fr) 2017-10-09 2020-08-19 Amgen Inc Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé
ES3069718T3 (en) 2017-11-03 2026-06-10 Amgen Inc System and approaches for sterilizing a drug delivery device
CA3079197A1 (en) 2017-11-06 2019-05-09 Amgen Inc. Drug delivery device with placement and flow sensing
MA50569A (fr) 2017-11-06 2020-09-16 Amgen Inc Ensembles de remplissage-finition et procédés associés
IL319987A (en) 2017-11-10 2025-06-01 Amgen Inc Plungers for drug delivery devices
JP7747438B2 (ja) 2017-11-16 2025-10-01 アムジエン・インコーポレーテツド 失速及び終点検出を有するオートインジェクタ
AU2018368340B2 (en) 2017-11-16 2024-03-07 Amgen Inc. Door latch mechanism for drug delivery device
ES3073501T3 (en) 2018-01-17 2026-07-13 Amgen Inc Drug delivery mechanism
WO2019173026A1 (en) 2018-03-07 2019-09-12 Amgen Inc. Controlled dispense syringe
US11890450B2 (en) 2018-03-09 2024-02-06 Amgen Inc. Backflow prevention mechanism for drug delivery device
WO2019178280A1 (en) 2018-03-13 2019-09-19 Amgen Inc. Sequential digestion of polypeptides for mass spectrometric analysis
WO2019178151A1 (en) 2018-03-13 2019-09-19 Amgen Inc. Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis
WO2019190647A1 (en) 2018-03-30 2019-10-03 Amgen Inc. Camera-based drug container inspection
US11583633B2 (en) 2018-04-03 2023-02-21 Amgen Inc. Systems and methods for delayed drug delivery
US10835685B2 (en) 2018-05-30 2020-11-17 Amgen Inc. Thermal spring release mechanism for a drug delivery device
US11083840B2 (en) 2018-06-01 2021-08-10 Amgen Inc. Modular fluid path assemblies for drug delivery devices
TWI890148B (zh) 2018-06-23 2025-07-11 美商建南德克公司 以pd-1軸結合拮抗劑、鉑劑及拓撲異構酶ii抑制劑治療肺癌之方法
EP3823611A1 (en) 2018-07-18 2021-05-26 Genentech, Inc. Methods of treating lung cancer with a pd-1 axis binding antagonist, an antimetabolite, and a platinum agent
CA3103682A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Delivery devices for administering drugs
CN112469454B (zh) 2018-07-24 2024-01-26 安进公司 用于施用药物的输送装置
US12303677B2 (en) 2018-07-24 2025-05-20 Amgen Inc. Hybrid drug delivery devices with optional grip portion and related method of preparation
WO2020023336A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Hybrid drug delivery devices with grip portion
WO2020023702A1 (en) 2018-07-25 2020-01-30 AskGene Pharma, Inc. Novel il-21 prodrugs and methods of use thereof
MA53320A (fr) 2018-07-31 2021-11-03 Amgen Inc Ensemble de trajet de fluide pour dispositif d'administration de médicament
IL280525B2 (en) 2018-08-08 2024-11-01 Genentech Inc Use of tryptophan derivatives and l-methionine for protein formulation
EP3836988A1 (en) 2018-08-17 2021-06-23 Amgen Inc. Activation mechanism for drug delivery device
AU2019342133B8 (en) 2018-09-21 2025-08-07 Genentech, Inc. Diagnostic methods for triple-negative breast cancer
CA3106452A1 (en) 2018-09-24 2020-04-02 Amgen Inc. Interventional dosing systems and methods
US12042642B2 (en) 2018-09-28 2024-07-23 Amgen Inc. Muscle wire escapement activation assembly for a drug delivery device
WO2020072577A1 (en) 2018-10-02 2020-04-09 Amgen Inc. Injection systems for drug delivery with internal force transmission
JP7547325B2 (ja) 2018-10-05 2024-09-09 アムジエン・インコーポレーテツド 投薬量インジケータを有する薬物送達デバイス
MA53913A (fr) 2018-10-15 2022-01-19 Amgen Inc Procédé d'assemblage de plate-forme pour dispositif d'administration de médicament
JP7719714B2 (ja) 2018-10-15 2025-08-06 アムジエン・インコーポレーテツド ダンピング機構を有する薬物送達装置
MA54057A (fr) 2018-11-01 2022-02-09 Amgen Inc Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament
TWI831847B (zh) 2018-11-01 2024-02-11 美商安進公司 部分針頭縮回之藥物遞送裝置及其操作方法
WO2020091956A1 (en) 2018-11-01 2020-05-07 Amgen Inc. Drug delivery devices with partial drug delivery member retraction
US12000775B2 (en) 2018-12-14 2024-06-04 Amgen Inc. System suitability method for use with protein concentration determination by slope
US12703762B2 (en) 2018-12-18 2026-08-11 Novartis Ag Reversal binding agents for anti-factor XI/XIa antibodies and uses thereof
US11534547B2 (en) 2019-01-24 2022-12-27 Amgen Inc. Drug delivery systems and methods with pressure sensitive control
JP7483723B2 (ja) 2019-01-24 2024-05-15 アムジエン・インコーポレーテツド 背圧検知による薬剤送達のシステム及び方法
WO2020167702A1 (en) 2019-02-12 2020-08-20 Amgen Inc. Take-home drug delivery system
WO2020167703A1 (en) 2019-02-12 2020-08-20 Amgen Inc. Continuous dosing systems and approaches
EP3923896A1 (en) 2019-02-12 2021-12-22 Amgen Inc. Systems and approaches for drug delivery device reconstitution
MX2021007722A (es) 2019-02-12 2021-08-05 Amgen Inc Sistemas y enfoques de dosificacion.
WO2020167542A1 (en) 2019-02-12 2020-08-20 Amgen Inc. Continuous dosing systems and approaches
US20220096747A1 (en) 2019-02-12 2022-03-31 Amgen Inc. Continuous dosing systems and approaches
CA3128233A1 (en) 2019-02-14 2020-08-20 Amgen Inc. Systems and methods for preparing a sample and performing a real-time assay of the sample
JP7530376B2 (ja) 2019-02-20 2024-08-07 アムジエン・インコーポレーテツド タンパク質の安定性を決定する方法
JP7570341B2 (ja) 2019-03-04 2024-10-21 アムジエン・インコーポレーテツド 高分子量種のインビボでの可逆性
US12078701B2 (en) 2019-03-27 2024-09-03 Amgen Inc. Methods of fingerprinting therapeutic proteins via a two-dimensional (2D) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products
EP3952950A1 (en) 2019-04-08 2022-02-16 Amgen Inc. Automated drug delivery device and container
MX2021012233A (es) 2019-04-09 2021-11-03 Amgen Inc Dispositivo de administracion de farmacos con mango inteligente.
JP7570347B2 (ja) 2019-04-17 2024-10-21 アムジエン・インコーポレーテツド オートインジェクタ用のカセット及び関連方法
EP3958934B1 (en) 2019-04-24 2025-04-09 Amgen Inc. Syringe sterilization verification assemblies and methods
US20220152304A1 (en) 2019-04-24 2022-05-19 Amgen Inc. Injector accessories
EP4517327A3 (en) 2019-06-05 2025-05-07 Amgen Inc. Methods of identifying attributes of therapeutic proteins
CN114341189A (zh) * 2019-06-12 2022-04-12 奥美药业有限公司 全新il-15前药及其应用
CA3137544A1 (en) 2019-06-20 2020-12-24 Amgen Inc. Wireless communication enabled drug delivery device and method
US20220249778A1 (en) 2019-07-18 2022-08-11 Amgen Inc. Sealing arrangement for drug delivery device
WO2021011716A1 (en) 2019-07-18 2021-01-21 Amgen Inc. Drug delivery device having pressurized vessel
AU2020321951A1 (en) 2019-08-01 2022-02-17 Amgen Inc. Drug delivery device with temperature measurement and related method
US20220273887A1 (en) 2019-08-23 2022-09-01 Amgen Inc. Drug delivery device with configurable needle shield engagement components and related methods
EP4025276A1 (en) 2019-09-03 2022-07-13 Amgen Inc. Activatable injection device for drug delivery
US12059555B2 (en) 2019-09-03 2024-08-13 Amgen Inc. Injection device for drug delivery and packaging for the injection device
US12594379B2 (en) 2019-09-12 2026-04-07 Amgen Inc. Backflow prevention mechanism for drug delivery device
MX2022002980A (es) 2019-09-16 2022-04-06 Amgen Inc Metodo para la esterilizacion externa de un dispositivo de suministro de farmacos.
ES3075614T3 (en) 2019-09-30 2026-08-06 Amgen Inc Drug delivery device
MX2022003607A (es) 2019-09-30 2022-04-20 Amgen Inc Dispositivo de administracion de farmacos.
BR112022005850A2 (pt) 2019-09-30 2022-06-21 Amgen Inc Dispositivo de administração de fármaco
PT4037735T (pt) 2019-09-30 2025-10-27 Amgen Inc Dispositivo de entrega de fármacos
US12102808B2 (en) 2019-09-30 2024-10-01 Amgen Inc. Drug delivery device
AU2020357708B2 (en) 2019-09-30 2025-06-26 Amgen Inc. Drug delivery device and methods of delivering a drug
US11660435B2 (en) 2019-10-07 2023-05-30 Amgen Inc. Light-activated ultrasonic delivery and manipulation of liquid medication from a drug reservoir
WO2021071831A1 (en) 2019-10-07 2021-04-15 Amgen Inc. Packages for pharmaceutical products and methods of assembly
WO2021071771A1 (en) 2019-10-07 2021-04-15 Amgen Inc. Drug delivery device with fingerprint sensor
EP4041342A1 (en) 2019-10-07 2022-08-17 Amgen Inc. Needle insertion mechanism for drug delivery device
AU2020363623A1 (en) 2019-10-08 2022-03-17 Amgen Inc. Cassette for an autoinjector and related methods
WO2021071694A1 (en) 2019-10-08 2021-04-15 Amgen Inc. Temperature indicator for drug delivery device
EP4041341A1 (en) 2019-10-08 2022-08-17 Amgen Inc. Needle insertion mechanism for drug delivery device
WO2021071886A1 (en) 2019-10-08 2021-04-15 Amgen Inc. Drug delivery device
US12370126B2 (en) 2019-10-18 2025-07-29 Amgen Inc. Systems and approaches for drug delivery device reconstitution
US20240066215A1 (en) 2019-10-18 2024-02-29 Amgen Inc. Drug delivery device and system
US20220331203A1 (en) 2019-10-18 2022-10-20 Amgen Inc. Systems and approaches for drug delivery device reconstitution
EP4045110A2 (en) 2019-10-18 2022-08-24 Amgen Inc. Drug delivery device and system
WO2021080828A1 (en) 2019-10-21 2021-04-29 Amgen Inc. Drug product container and drug delivery system
WO2021081186A1 (en) 2019-10-24 2021-04-29 Amgen Inc. Drug delivery device and system
US20220378657A1 (en) 2019-10-24 2022-12-01 Amgen Inc. Systems and components for drug delivery and components for preparation of the same
WO2021081321A1 (en) 2019-10-24 2021-04-29 Amgen Inc. Systems and approaches for drug delivery
WO2021081283A1 (en) 2019-10-24 2021-04-29 Amgen Inc. Drug delivery device
US12427241B2 (en) 2019-10-24 2025-09-30 Amgen Inc. Systems and methods for drug delivery
US20220395635A1 (en) 2019-11-07 2022-12-15 Amgen Inc. Drug delivery system and method of use
EP4069340B1 (en) 2019-12-02 2025-10-15 Amgen Inc. Lockout mechanism for drug delivery device
US20230347075A1 (en) 2019-12-05 2023-11-02 Amgen Inc. Flow restrictor for drug delivery device
AU2021205981A1 (en) 2020-01-11 2022-07-14 AskGene Pharma, Inc. Novel masked cytokines and methods of use thereof
MX2022008488A (es) 2020-01-13 2022-08-02 Amgen Inc Extractores de protectores de aguja, dispositivos de suministro de farmacos y metodos relacionados.
CA3167020A1 (en) 2020-02-24 2021-09-02 Amgen Inc. Containers and systems for use during external sterilization of drug delivery devices
US20230173198A1 (en) 2020-03-16 2023-06-08 Amgen Inc. Drug delivery member insertion sensing assemblies, drug delivery devices, and related methods
EP4121145A1 (en) 2020-03-17 2023-01-25 Amgen Inc. Controlled dispense syringe
US12136359B2 (en) 2020-04-28 2024-11-05 Amgen Inc. Packaging label
MX2022014688A (es) 2020-05-22 2022-12-16 Amgen Inc Sistema de almacenamiento y metodo para almacenar y transportar medicamentos.
WO2021257503A1 (en) 2020-06-16 2021-12-23 Genentech, Inc. Methods and compositions for treating triple-negative breast cancer
KR20230061408A (ko) 2020-09-02 2023-05-08 암젠 인크 약제 보관 상자용 개봉 용이성 장치
EP4210805A1 (en) 2020-09-09 2023-07-19 Amgen Inc. Swallowable drug delivery devices
WO2022055761A1 (en) 2020-09-11 2022-03-17 Amgen Inc. Inline uv flow device for sterilizing flow cytometry sheath fluid
JP7872263B2 (ja) 2020-09-18 2026-06-09 アムジエン・インコーポレーテツド ペプチドマッピング分析のための試料を処理する方法
CA3192737A1 (en) 2020-10-12 2022-04-21 Amgen Inc. Long-term medicament storage apparatus and methods
AU2021374583A1 (en) 2020-11-04 2023-04-20 Amgen Inc. Drug delivery device assembly and accessory for drug delivery device
JP2023549083A (ja) 2020-11-04 2023-11-22 アムジエン・インコーポレーテツド 薬物送達デバイスアセンブリ及び薬物送達デバイス用アクセサリ
CA3196037A1 (en) 2020-11-04 2022-05-12 Amgen Inc. Drug delivery device assembly and accessory for drug delivery device
AU2021376245A1 (en) 2020-11-04 2023-04-13 Amgen Inc. Drug delivery device assembly and accessory for drug delivery device
EP4240747A1 (en) 2020-11-05 2023-09-13 Amgen Inc. Materials and methods for protein processing
WO2022169724A1 (en) 2021-02-03 2022-08-11 Amgen Inc. Coaxial needle adapter and guide bracket for robotic liquid handling platform
WO2022169725A1 (en) 2021-02-03 2022-08-11 Amgen Inc. High-throughput automated reconstitution of lyophilized drug product
US20240103025A1 (en) 2021-02-03 2024-03-28 Amgen Inc. Systems and approaches for drug processing
WO2022192100A1 (en) 2021-03-08 2022-09-15 Amgen Inc. Manufacturing process for hollow plunger rod
AU2022234298A1 (en) 2021-03-10 2023-08-31 Amgen Inc. Drug delivery device, subassembly for drug delivery device, syringe holder, and method of assembly
CA3209084A1 (en) 2021-03-10 2022-09-15 Amgen Inc. Drug delivery device
CA3211430A1 (en) 2021-03-10 2022-09-15 Amgen Inc. Drug delivery device having removable cap
JP2024510668A (ja) 2021-03-25 2024-03-08 アムジエン・インコーポレーテツド 薬物送達デバイス
CA3213768A1 (en) 2021-03-31 2022-10-06 Amgen Inc. Sound-detection based injection time measurement system for drug delivery devices
AU2022261835C1 (en) 2021-04-22 2026-07-16 Amgen Inc. Methods and systems for automated syringe quality evaluation
JP2024521620A (ja) 2021-04-28 2024-06-04 アムジエン・インコーポレーテツド 患者の外来処置システム及び関連する方法
EP4341945A1 (en) 2021-05-17 2024-03-27 Amgen Inc. Feedback system and method for a drug product
BR112023024278A2 (pt) 2021-05-21 2024-01-30 Amgen Inc Método de otimizar uma receita de enchimento para um recipiente de fármacos
WO2022256199A1 (en) 2021-06-01 2022-12-08 Amgen Inc. Lyophilization system
WO2022260925A1 (en) 2021-06-08 2022-12-15 Amgen Inc. Drug delivery devices, finger-grip elements, and related methods
TW202310885A (zh) 2021-06-17 2023-03-16 美商安進公司 具有減震器的藥物遞送裝置
JP2024525407A (ja) 2021-06-23 2024-07-12 アムジエン・インコーポレーテツド シリンジ、アセンブリ、及び製造方法
WO2023278125A1 (en) 2021-06-28 2023-01-05 Amgen Inc. Safety device for drug delivery system
EP4370087A1 (en) 2021-07-16 2024-05-22 Amgen Inc. Systems and approaches for drug processing single-use hardware
IL310308A (en) 2021-09-29 2024-03-01 Amgen Inc Apparatuses, systems and methods for plunger-stopper depth measurement in pre-filled syringes
US20240424223A1 (en) 2021-10-06 2024-12-26 Amgen Inc. Impact Activated Brake Feature for Drug Delivery Device
CN118019555A (zh) 2021-10-06 2024-05-10 美国安进公司 用于药物递送装置的撞击激活式固位特征
WO2023064119A1 (en) 2021-10-11 2023-04-20 Amgen Inc. Characterization apparatus for drug delivery devices or subcomponents thereof
MX2024005456A (es) 2021-11-05 2024-05-22 Amgen Inc Dispositivos de administracion de farmaco, componentes para usarse dentro de los dispositivos de administracion de farmaco.
AU2022388727A1 (en) 2021-11-09 2024-05-16 Amgen Inc. Production of therapeutic proteins
JP2024540611A (ja) 2021-11-29 2024-10-31 アムジエン・インコーポレーテツド プランジャロッド除去力に関する方法及び固定具
US20250009976A1 (en) 2021-12-03 2025-01-09 Amgen Inc. Stopper placement in a syringe
IL314557A (en) 2022-03-11 2024-09-01 Amgen Inc Automatic injector with adjustable depth
WO2023196111A1 (en) 2022-04-06 2023-10-12 Amgen Inc. Packaging for drug delivery device
KR20250044344A (ko) 2022-08-04 2025-03-31 노파르티스 파르마 아게 아토피 피부염의 치료에 유용한 il-15 저해제
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment
EP4572824A1 (en) 2022-08-18 2025-06-25 Amgen Inc. Needle shield assembly for a syringe
AU2023326190A1 (en) 2022-08-18 2025-01-23 Amgen Inc. Needle shield for syringe
CA3265370A1 (en) 2022-08-30 2024-03-07 Amgen Inc. SYSTEM AND METHOD FOR LIMITING THE NUMBER OF SUBVISIBLE PARTICLES IN A SYRINGE
TW202507261A (zh) 2023-05-01 2025-02-16 美商安進公司 用於使用集成人工智慧基於拉曼光譜法鑒定生物產品之可配置掌上型生物分析儀
CN118894934A (zh) 2023-05-05 2024-11-05 北京智仁美博生物科技有限公司 抗人il-15的抗体及其用途
CN121311767A (zh) 2023-06-14 2026-01-09 百时美施贵宝公司 糖蛋白的近实时唾液酸定量
JP2026525282A (ja) 2023-07-14 2026-07-29 アムジエン・インコーポレーテツド 注入デバイスのためのモニタリングシステム及び方法
AU2024353933A1 (en) 2023-09-26 2026-02-12 Amgen Inc. Packaging systems for medical devices
WO2025101602A1 (en) 2023-11-07 2025-05-15 Amgen Inc. Methods of analyzing amino acid content of a therapeutic protein
CN117209605B (zh) * 2023-11-09 2024-01-30 北京百普赛斯生物科技股份有限公司 特异性结合il-15的抗体及其应用
AU2024390123A1 (en) 2023-11-28 2026-07-16 Amgen Inc. Automated systems and methods for foil packaging components
WO2025136894A1 (en) 2023-12-18 2025-06-26 Amgen Inc. Ampoule adapter and method of use
CN122421996A (zh) 2023-12-20 2026-07-17 美国安进公司 用于药物施用的包装
WO2025144700A1 (en) 2023-12-27 2025-07-03 Absci Corporation Nanobody library screening using bacterial surface display
TW202600184A (zh) 2024-02-28 2026-01-01 美商安進公司 藥物遞送裝置
AR134332A1 (es) 2024-02-29 2026-01-07 Amgen Inc Sistemas de embajale sostenibles y modulares para envases de uso farmacéutico
WO2025213011A1 (en) 2024-04-05 2025-10-09 Amgen Inc. Method of assessing stopper movement in a drug delivery device
WO2025214468A1 (zh) * 2024-04-12 2025-10-16 福佑泰生物制药公司 抗il-15抗体以及其用途
TW202606778A (zh) 2024-04-19 2026-02-16 美商安進公司 藥物遞送裝置
WO2025255028A1 (en) 2024-06-03 2025-12-11 Amgen Inc. High-throughput liquid chromatography-mass spectrometry-based peptide mapping
WO2026030152A1 (en) 2024-07-29 2026-02-05 Amgen Inc. System and method for assessing transferability of a fill recipe
WO2026076183A1 (en) 2024-10-04 2026-04-09 Amgen Inc. Systems, devices, and methods for measuring components
WO2026084717A1 (en) 2024-10-18 2026-04-23 Amgen Inc. Damper overfill chamber to increase functional robustness regarding variance in parts and processes
WO2026090381A1 (en) 2024-10-24 2026-04-30 Amgen Inc. Drug delivery device and related methods
WO2026096589A1 (en) 2024-10-30 2026-05-07 Amgen Inc. Drug delivery device and related methods
WO2026112197A1 (en) 2024-11-20 2026-05-28 Amgen Inc. Systems and methods for inspecting drug containers
WO2026117552A1 (en) 2024-11-27 2026-06-04 Amgen Inc. Drive assembly for a drug delivery device and related methods
WO2026136486A1 (en) 2024-12-18 2026-06-25 Amgen Inc. Drug delivery devices and flange extension members
WO2026136851A1 (en) 2024-12-20 2026-06-25 Amgen Inc. Methods of diethylenetriaminepentaacetic acid (dtpa) quantification
WO2026151929A1 (en) 2025-01-09 2026-07-16 Amgen Inc. Systems and methods for inspecting products on a production line
WO2026155939A1 (en) 2025-01-15 2026-07-23 Amgen Inc. Optic labels for drug storage containers

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1690935A3 (en) * 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
US6255458B1 (en) * 1990-08-29 2001-07-03 Genpharm International High affinity human antibodies and human antibodies against digoxin
US5574138A (en) 1993-03-08 1996-11-12 Immunex Corporation Epithelium-derived T-cell factor
US5591630A (en) * 1994-05-06 1997-01-07 Immunex Corporation Monoclonal antibodies that bind interleukin-15 receptors
US5795966A (en) 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
EP0823257B1 (en) 1995-04-02 2002-08-07 Chugai Seiyaku Kabushiki Kaisha Medicinal composition for curing thrombocytopenia
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5660824A (en) 1995-05-24 1997-08-26 Grabstein; Kenneth H. Muscle trophic factor
ES2233974T3 (es) * 1995-09-11 2005-06-16 Kyowa Hakko Kogyo Co., Ltd. Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana.
JP2001502521A (ja) 1996-04-26 2001-02-27 ベス イスラエル デアコネス メディカル センター インターロイキン―１５の拮抗剤
ES2191827T3 (es) 1996-10-17 2003-09-16 Immunomedics Inc Conjugado de toxina no antigenica y proteina de fusion de un sistema receptor de penetracion intracelular.
EP0971728B1 (en) 1997-02-21 2002-12-11 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Use of interleukin-15
DE69841452D1 (de) * 1997-02-28 2010-03-04 Kyowa Hakko Kirin Co Ltd Humanes Chromosomfragment und ein Vektor, der dies enthält
GB9814892D0 (en) 1998-07-10 1998-09-09 Kennedy Rheumatology Inst Treatment of celiac disease
AU6689700A (en) * 1999-07-06 2001-01-22 Silvia Bulfone-Paus Method of treating psoriasis with il-15 antagonist
KR100911951B1 (ko) 2001-08-23 2009-08-13 젠맵 에이/에스 인터루킨 15 (ｉｌ-15)에 대하여 특이적인 인간 항체

Also Published As

Publication number Publication date
ZA200401144B (en) 2005-05-12
CN1571836A (zh) 2005-01-26
RS51829B (sr) 2012-02-29
WO2003017935A3 (en) 2003-08-14
CY1112447T1 (el) 2015-12-09
JP4359503B2 (ja) 2009-11-04
IL160358A (en) 2010-12-30
CA2456648A1 (en) 2003-03-06
MXPA04001486A (es) 2004-10-27
US7153507B2 (en) 2006-12-26
EA200400345A1 (ru) 2004-12-30
HUP0402653A3 (en) 2010-01-28
PT1425389E (pt) 2012-02-07
US20030138421A1 (en) 2003-07-24
HU229776B1 (hu) 2014-07-28
NO333152B1 (no) 2013-03-18
ES2375271T3 (es) 2012-02-28
NO20040752L (no) 2004-04-24
CN100557018C (zh) 2009-11-04
AU2002332628B2 (en) 2007-07-26
DK1425389T3 (da) 2012-01-30
CA2456648C (en) 2011-08-16
WO2003017935A9 (en) 2003-04-10
WO2003017935A2 (en) 2003-03-06
JP2005503151A (ja) 2005-02-03
KR100911951B1 (ko) 2009-08-13
BR0212136A (pt) 2004-12-07
HUP0402653A2 (hu) 2005-03-29
EP1425389A4 (en) 2007-08-01
HK1066828A1 (en) 2005-04-01
EA014802B1 (ru) 2011-02-28
EP1425389B1 (en) 2011-11-02
YU15104A (sh) 2006-08-17
NZ531211A (en) 2007-04-27
EP1425389A2 (en) 2004-06-09
PL371946A1 (pl) 2005-07-11
IL160358A0 (en) 2004-07-25
SI1425389T1 (sl) 2012-02-29
JP2009256354A (ja) 2009-11-05
KR20040047796A (ko) 2004-06-05
PL217752B1 (pl) 2014-08-29

Similar Documents

Publication Publication Date Title
LTC3284753I2 (pl)
DK1425389T3 (da) Interleukin-15-(IL-15)-specifikke humane antistoffer
TW200500378A (en) Human antibodies specific for interleukin 15 (IL-15)
AU2003303237A8 (en) Human monoclonal antibodies to epidermal growth factor receptor (egfr)
EP1590364A4 (en) HUMAN MONOCLONAL ANTIBODY TO INTERLEUKIN 8 (IL-8)
DE60037896D1 (de) Menschliche antikörper gegen her2/neu
DK1210374T3 (da) Humane, monoklonale antistoffer over for prostataspecifikt membranantigen
EA200500835A1 (ru) Человеческие моноклональные антитела против cd25
WO2003064606A3 (en) Human monoclonal antibodies to prostate specific membrane antigen (psma)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1425389

Country of ref document: EP